Gentamicin Sulfate Injection USP 80 mg/2 mL(40 mg/mL as Gentamicin), 2 mL Single-dose Fliptop Vial, (NDC 0409-1207-13), Rx only, Manufactured by Hospira, Inc, Lake Forest, IL 60046 USA.
Published July 17, 2013 · Recall initiated: May 2, 2013
Summary
FDA records drug Class II recall D-686-2013, published July 17, 2013 and initiated May 2, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 168,300 vals; Lot: Lot 07-067-DK Exp. 07/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: visible particles were identified floating in the primary container.
What to do
Voluntary: Firm initiated · Letter
Get an email if GENTAMICIN SULFATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- GENTAMICIN SULFATE
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot 07-067-DK Exp. 07/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDABenztropine Mesylate Injection, USP, 2 mg/2 mL (1 mg/1 mL), 2 mL Single Dose Vial, Rx only, labeled as a)July 17, 2013
- FDANimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blisterJuly 17, 2013
- FDABalziva(TM) (norethindrone and ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, 28 day regimen, Rx only, BarrJuly 17, 2013
- FDAFolic Acid Injection, USP, 5 mg/mL, For IM, IV or SC Use, 10 mL, Multiple Dose Vial, Rx only, APPJuly 17, 2013
- FDAJolessa(R) (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, 91 day regimen, Rx only,July 17, 2013
- FDAErrin (norethindrone tablets, USP), 0.35 mg, 6 blister cards per carton, 28 tablets each, 28 day regimen, RxJuly 17, 2013
Questions about this recall
Was Gentamicin Sulfate Injection USP 80 mg/2 mL(40 mg/mL as Gentamicin), 2 mL Single-dose Fliptop Vial, (NDC 0409-1207-13), Rx only, Manufactured by Hospira, Inc, Lake Forest, IL 60046 USA. recalled?
Yes. FDA published recall D-686-2013 on July 17, 2013. Reported hazard: Presence of Particulate Matter: visible particles were identified floating in the primary container.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: GENTAMICIN SULFATE.